Your browser doesn't support javascript.
loading
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Lele, S B; Piver, M S.
Afiliación
  • Lele SB; Department of Gynecologic Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263.
Gynecol Oncol ; 33(1): 6-8, 1989 Apr.
Article en En | MEDLINE | ID: mdl-2467845
Sixty-nine patients with recurrent cervical carcinoma were treated with weekly cisplatin induction chemotherapy. A 27% objective response was obtained in 67 evaluable patients. The highest responses were seen in liver (33%), supraclavicular nodes (40%), and lung (48%), whereas only one out of 24 (4.2%) patients with central recurrence responded. Consolidation therapy with cisplatin combinations administered on a monthly basis did not enhance response to cisplatin. Cisplatin induction therapy was well tolerated with minimal toxicity.
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Cisplatino / Recurrencia Local de Neoplasia Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 1989 Tipo del documento: Article Pais de publicación: Estados Unidos
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Cuello Uterino / Cisplatino / Recurrencia Local de Neoplasia Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 1989 Tipo del documento: Article Pais de publicación: Estados Unidos